Skip to content

A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients

A Plant Based High Protein Diet to Improve Nutritional Outcomes in Dialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02360748
Acronym
PBPD
Enrollment
8
Registered
2015-02-11
Start date
2015-10-31
Completion date
2017-09-15
Last updated
2018-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-Stage Renal Disease, Malnutrition

Brief summary

The study proposes that addition of high protein plant based diet will improve serum albumin as well serum phosphate for patients with End Stage Renal Disease (ESRD) on Dialysis. Patient will be provided additional food items to help improve their nutritional status.

Detailed description

The purpose of this study is to improve the albumin and nutritional status of patient with ESRD on dialysis. Serum albumin is a marker to show how well the patient's overall nutrition is. When albumin level drops it signifies poor outcome in dialysis patients both in terms of complications as well as mortality. Our goal on dialysis is to improve serum albumin level as close to normal as possible. This study intends to also improve phosphorus level by adding high protein sources which are plant based. In this study we intend to add certain plant based food items which are high in protein content. Studies have shown that these particular food items considerably increase serum albumin level but at the same time they are safe as they do not increase the phosphorous levels in kidney patients. Patients will be provided the additional food items and all their nutritional parameters will be monitored at baseline and during the study period of one month

Interventions

DIETARY_SUPPLEMENTPlant based high protein food items

Patients will add high protein plant based food items to their diet

Sponsors

Fresenius Medical Care North America
CollaboratorINDUSTRY
DaVita, Inc.
CollaboratorINDUSTRY
Food Care, Inc.
CollaboratorINDUSTRY
Ochsner Health System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* ESRD Patients on dialysis with an albumin of \<4.0 with the ability to consent and willingness to enroll in the study

Exclusion criteria

* Other exclusions include * liver cirrhosis, * cardiac cirrhosis, * dysphagia due to an old Cerebrovascular accident / muscular dystrophy, * Hyperkalemia (\>5.5)

Design outcomes

Primary

MeasureTime frameDescription
Nutritional Parameters, bone and mineral metabolismone monthalbumin will improve on high protein plant based diet; we will measure patients' baseline nutritional parameters which will include serum album; Calcium and phosphate levels and then follow the same parameters on the dietary intervention

Secondary

MeasureTime frameDescription
Phosphorous measurements will be followed during the course of the study and on completionone monthHyperphosphatemia will improve on plant based high protein diet
Obesityone monthOn this intervention we will follow patients' weight as a secondary outcome in obese patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026